Business Description
Rebus Hldgs Inc
NAICS : 325412
SIC : 2834
ISIN : US45782A2050
Description
Rebus Hldgs Inc is an early-stage, pre-revenue, pharmaceutical company that is focused on the development of prodrug cancer therapeutics for the treatment of disease. The company along with its subsidiaries is engaged in the production of small-molecule adenosine receptor modulators. Adenosine is an extracellular signaling molecule that regulates multiple aspects of tissue function and specifically plays a role in immunity and inflammation.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | -623.33 | |||||
| Debt-to-Equity | -0.06 | |||||
| Debt-to-EBITDA | 0.52 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 90.9 | |||||
| 3-Year EPS without NRI Growth Rate | 96.4 | |||||
| 3-Year FCF Growth Rate | 94 | |||||
| 3-Year Book Growth Rate | 94.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 0.01 | |||||
| 9-Day RSI | 2.29 | |||||
| 14-Day RSI | 15.22 | |||||
| 6-1 Month Momentum % | -98.53 | |||||
| 12-1 Month Momentum % | -99.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1470.8 | |||||
| Shareholder Yield % | 2610 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | Neg. Equity | |||||
| ROA % | 681.82 | |||||
| ROIC % | -16.51 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 0.01 | |||||
| EV-to-EBIT | 0.52 | |||||
| EV-to-EBITDA | 0.52 | |||||
| EV-to-FCF | -0.53 | |||||
| Earnings Yield (Greenblatt) % | 192.31 | |||||
| FCF Yield % | -19400 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:RBSH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rebus Hldgs Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0.008 | ||
| Beta | -0.67 | ||
| Volatility % | 137.47 | ||
| 14-Day RSI | 15.22 | ||
| 14-Day ATR ($) | 0.000024 | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | -99.33 | ||
| 52-Week Range ($) | 0.0001 - 0.02255 | ||
| Shares Outstanding (Mil) | 32.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rebus Hldgs Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rebus Hldgs Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Rebus Hldgs Inc Frequently Asked Questions
What is Rebus Hldgs Inc(RBSH)'s stock price today?
The current price of RBSH is $0.00. The 52 week high of RBSH is $0.02 and 52 week low is $0.00.
When is next earnings date of Rebus Hldgs Inc(RBSH)?
The next earnings date of Rebus Hldgs Inc(RBSH) is .
Does Rebus Hldgs Inc(RBSH) pay dividends? If so, how much?
Rebus Hldgs Inc(RBSH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers